Active, not recruitingNo phase
Clinical Outcome and Cytokine Expression After TKA
Key facts
- Who runs it
- Technische Universität Dresden
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people enrolled
- Started
- 4 Jan 2017
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Coated Total Knee Arthroplasty
- Standard Total Knee Arthroplasty
- Record updated
- 7 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Primary and secondary osteoarthritis
- understanding of german language
Who cannot take part
- existence of other joint implants
- necessity of constrained TKA
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results
The 2 groups in the trial
- Coated Total Knee ArthroplastyTreatment being tested
Implantation coated Total Knee Arthroplasty
- Standard Total Knee ArthroplastyExisting treatment, for comparison
Implantation Standard Total Knee Arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical Outcome and Cytokine Expression in Blood After Coated in Comparison to Uncoated TKA
- Record updated
- 7 August 2024